
Help accelerate research for
Sickle Cell Disease
See if you qualify to participate in this at-home research study today. You can contribute to the development of new ways to manage Sickle Cell Disease.
By clicking sign up now, you agree to our privacy policy and terms and conditions consent to answer screening questions for potential enrollment in an active research study.
By clicking continue, you agree to our privacy policy and terms and conditions consent to answer screening questions for potential enrollment in an active research study.
Study Name:
PROGRESS Study
A Low-Interventional Study of an Electronic Sickle Cell Disease Patient Reported Outcomes in Sickle Cell Participants
This study is for people with:
Sickle Cell Disease
Number of participants:
150 participants
Sponsored By:
Pfizer
Compensation Up To:
$1305
Purpose:
The purpose of this study is to learn more about painful crisis in people with Sickle Cell Disease. For this reason, Pfizer is conducting a study to understand how people with Sickle Cell Disease feel on a daily basis, treat these painful episodes including if they treat themselves at home or go to a doctor’s office/emergency room, as well as the types of medications that are taken during these episodes.
Procedures & Assessments:
If you are enrolled, a member of the study team will have a monthly phone call with you about 6 times and will visit you in your home one time. You will receive an electronic study diary from a member of the study staff during your first in-home study visit. You will be asked to type in the electronic study diary that describes how you are feeling on a daily basis for 6 months. Each diary completion takes 5 minutes to complete. You will be asked to provide blood samples once, at the beginning of the study. These blood samples may help Pfizer better understand Sickle Cell Anemia.
You may qualify if you:
- Are 18 years of age or older
- Confirmed diagnosis of stable SCD (HbS/S or HbS/β0 -thalassemia) at screening.
- Live in United States
You may not qualify if you:
- Have evidence or history of clinically significant hematological (non-SCD), renal, endocrine, pulmonary, gastrointestinal, cardiovascular (including overt stroke but excluding silent cerebral infarct), hepatic (excluding cholelithiasis), psychiatric or neurological disease as assessed from medical records.
- Have a history of simple transfusion less than 4 weeks of Day 1 as assessed from medical records.
- Are pregnant
Participate from home!
United States
How it Works
It’s a simple, three-step process.

Submit a health profile by answering basic questions about your medical history.

Speak with a research coordinator to learn more about what is required to participate.

Complete study requirements from home with the help of our mobile health staff.
Who We Are
We are the missing link in clinical trials, connecting patients and researchers seamlessly and conveniently using a mobile health platform to advance medical research from home. Our goal is to develop mobile technologies that empower patients to participate in research for conditions that matter most to them, regardless of their location or ability to travel.
We work directly with patients and advocacy groups to accelerate research through convenience and transparency while guiding each patient every step of the way.
Sanguine's Expertise in Accelerating Research

our community

member has participated

completed by Sanguine
